Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATLANTIC: Aflibercept Monotherapy vs Combo with PDT in PCV
NCT02495181Phase 4Completed
- Sponsor
- AIBILI
- Start
- Nov 2015
- Primary completion
- Aug 2017
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 4 trial of aflibercept in polypoidal choroidal vasculopathy (PCV), sponsored by AIBILI. Started Nov 2015; status: completed.
02
Drugs
aflibercept
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT02495181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495181.